What should I know first?

NMDA stands for N-methyl-D-aspartate. NMDA receptors can allow electrically charged particles to pass through a cell membrane under particular conditions. They participate in synaptic communication and plasticity; they are not a diagnosis or a test for depression.

Important Distinctions

Ketamine and esketamine are NMDA receptor antagonists. Blocking this receptor is an established action, but the sequence leading to antidepressant benefit is not fully understood. A simplified diagram cannot represent every co-agonist, voltage effect or brain circuit.

Sources and References

  1. Ketalar: current US prescribing information (revised March 2026)
  2. Spravato 28 mg nasal spray: UK Summary of Product Characteristics

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

  3. Ketamine and neural changes: animal research and its limits

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top